Knowledge Center

Filter your results:

685 Results Found

This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the supply chain.
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply chain executives united to re-engineer and advance the future of the healthcare supply chain. SMI has provided AHRMM with free supply chain industry resources. To access the resources, visit www.smisupplychain.com or click on the topic below. You will be prompted to register with SMI in order to access the free tools.
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based value analysis. Michael Louviere, System VP of Supply Chain at OHS shares his insights on what he calls a 'new adventureattempting to support best practices by collecting clinical evidence and synthesizing it to ensure that clinical practice is based on integrating individual clinical expertise with the best available relevant external clinical evidence from systematic research.
A sample of wholesale pharmacy distributor request for proposal. Sample RFP for Wholesale Pharmacy Distributor  
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services departments.
This page provides information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.
How-to guide to managing IV disruptions. Download Tool
The Food and Drug Administration (FDA) UDI system is being phased in over several years. The first sunrise date (certain Class III devices) occurred 09/24/14. Recognizing UDI implementation will take time, healthcare supply chain and risk management professionals should be aware of already-implemented changes in the FDA’s adverse event reporting methodology. One of the changes required immediately is the use of the UDI in adverse event reporting.
To provide administrative support to the TCH IDS contracts process.
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation between cost, quality, and outcomes.
Please see a sample of a Architect RFP below - you will find this short document covers all the basics, and you can tailor it to your needs.
Read examples of Green Light Projects illustrating how the performance improvement measures on the Sustainability Roadmap for Hospitals website can help your organization achieve sustainable design and operations.
Read how UPMC Health System is improving lives through redefined models of health care delivery, technological innovation and cutting-edge medical research.
Numerous papers written recently predict the impact of the economic downturn on the healthcare industry. Many of these predictions are now headlines – reduced labor budgets, declines in elective and out-patient volumes/surgeries, and smaller, or in some instances, no capital budgets. Because of the role supply chain plays in the financial well-being of an organization and the current economic environment, supply chain leaders can anticipate:
In the fall of 2014, the University of Houston conducted a national study on hospital supply chain. With the support and participation from the AHRMM community, the University of Houston collected data from 266 hospitals and at least 60 percent of the respondents have an official designation of supply chain director or higher. Thank you to those who participated in the study. Your contribution is invaluable in helping academic institutions, AHRMM, and collaborating organizations better understand supply chain perspectives and best practices.  
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decisions. CER is designed to support healthcare decisions by providing objective conclusions after comparing the effectiveness, benefits, and potential harm of various medical equipment, devices, or treatment options for specific episodes of care or states of disease.   By using objective data provided by CER, healthcare supply chain professionals have the ability to: